Massimo Lopez

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
De Luca C; Vici P; Carpano S; Sergi D; Viola G; Corsetti S; Toglia G; Pinnarò P; Vizza E; Amodio A; Paoletti G; Lopez M
Recent advances in the adjuvant treatment of early breast cancer.
Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Fattoruso S I S; Rossi S; Di Lauro L; Botti C; Vici P; Lopez M
[Development of docetaxel in the adjuvant chemotherapy of breast cancer]

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Massimo Lopez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: De Luca C; Vici P; Carpano S; Sergi D; Viola G; Corsetti S; Toglia G; Pinnarò P; Vizza E; Amodio A; Paoletti G; Lopez M
Recent advances in the adjuvant treatment of early breast cancer.
La Clinica terapeutica 2009;160(4):299-306.
2009: Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Anticancer research 2009;29(5):1841-5.
2008: Fattoruso S I S; Rossi S; Di Lauro L; Botti C; Vici P; Lopez M
[Development of docetaxel in the adjuvant chemotherapy of breast cancer]
La Clinica terapeutica 2008;159(5):369-76.
2008: Vici Patrizia; Di Lauro Luigi; Sergi Domenico; Foggi Paolo; Viola Giuditta; Mottolese Marcella; Giotta Francesco; Fattoruso Silvia I S; Corsetti Serena; Giannarelli Diana; Botti Claudio; Lopez Massimo
A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.
Oncology 2008;75(3-4):175-81.
2007: Viola G; Sergi D; Conti F; Lopez M
[Neoadjuvant endocrine therapy for locally advanced breast cancer]
La Clinica terapeutica 2007;158(5):441-52.
2007: Di Lauro L; Nunziata C; Arena M G; Foggi P; Sperduti I; Lopez M
Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma.
British journal of cancer 2007;97(5):593-7.
2007: Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate M I; Ferranti F R; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results]
La Clinica terapeutica 2007;158(4):331-41.
2007: Conti F; Sergi D; Foggi P; Abbate M I; Lopez M
[New combination chemotherapy regimens in the primary treatment of operable breast cancer]
La Clinica terapeutica 2007;158(1):55-75.
2006: Cauchi C; Visca P; Donati P; Lopez M
[Skin adnexal tumors]
La Clinica terapeutica 2006;157(4):363-76.
2006: Maiello E; Giuliani F; Gebbia V; Di Renzo N; Pezzella G; Romito S; Mallamaci R; Lopez M; Colucci G;
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii55-9.
2006: Vici P; Capomolla E; Foggi P; Carpano S; Conti F; Paoletti G; Cauchi C; Giacinti L; Leonetti C; Giannarelli D; Lopez M
High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.
Journal of experimental & clinical cancer research : CR 2006;25(1):39-44.
2005: De Placido S; Lopez M; Carlomagno C; Paoletti G; Palazzo S; Manzione L; Iannace C; Ianniello G P; De Vita F; Ficorella C; Farris A; Pistillucci G; Gemini M; Cortesi E; Adamo V; Gebbia N; Palmeri S; Gallo C; Perrone F; Persico G; Bianco A R
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
British journal of cancer 2005;93(8):896-904.
2005: Di Lauro L; Belli F; Arena M G; Carpano S; Paoletti G; Giannarelli D; Lopez M
Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1498-502.
2005: Zupi Gabriella; Scarsella Marco; D'Angelo Carmen; Biroccio Annamaria; Paoletti Giancarlo; Lopez Massimo; Leonetti Carlo
Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells.
Cancer biology & therapy 2005;4(8):866-71.
2005: Maiello E; Gebbia V; Giuliani F; Paoletti G; Gebbia N; Borsellino N; Cartenì G; Pezzella G; Manzione L; Romito S; Lopez M; Colucci G;
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv56-60.
2005: Vici Patrizia; Foggi Paolo; Colucci Giuseppe; Capomolla Elisabetta; Brandi Mario; Giotta Francesco; Gebbia Nicola; Di Lauro Luigi; Valerio Maria Rosaria; Paoletti Giancarlo; Belli Franca; Pizza Carmine; Giannarelli Diana; Lopez Massimo
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.
Anticancer research 2005;25(2B):1309-14.
2004: Brandi Mario; Vici Patrizia; Lopez Massimo; Valerio Maria Rosaria; Giotta F; Gebbia Nicola; Schittulli Francesco; Colucci Giuseppe;
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study.
Seminars in oncology 2004;31(2 Suppl 5):13-9.
2002: Naglieri Emanuele; Lopez Massimo; Lelli Giorgio; Morelli Francesco; Amodio Antonella; Di Tonno Pasquale; Gebbia Nicola; Di Seri Marisa; Chetri Maria Concetta; Rizzo Pietro; Abbate Ines; Casamassima Addolorata; Selvaggi Francesco Paolo; Colucci Giuseppe
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.
Anticancer research 2002;22(5):3045-51.
2002: Vici Patrizia; Colucci Giuseppe; Gebbia Vittorio; Amodio Antonella; Giotta Francesco; Belli Franca; Conti Francesca; Gebbia Nicola; Pezzella Giuseppe; Valerio Maria Rosaria; Brandi Mario; Pisconti Salvatore; Durini Ernesto; Giannarelli Diana; Lopez Massimo
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2689-94.
2002: Lopez Massimo; Vici Patrizia; Di Lauro Luigi; Carpano Silvia
Increasing single epirubicin doses in advanced soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1329-34.
2002: Colucci Giuseppe; Giuliani Francesco; Gebbia Vittorio; Biglietto Maria; Rabitti Piergiorgio; Uomo Generoso; Cigolari Silvio; Testa Antonio; Maiello Evaristo; Lopez Massimo
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
Cancer 2002;94(4):902-10.
2001: Lopez M
[Molecular treatment of cancer. Imatinib]
La Clinica terapeutica 2001;152(6):399-407.
2001: Lopez M
[Successful neoplasm chemotherapy. Remission of Hodgkin's disease. V]
La Clinica terapeutica 2001;152(5):323-8.
2001: Lopez M
[Early clinical applications of radiotherapy]
La Clinica terapeutica 2001;152(4):267-70.
2001: Lopez M
[Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV]
La Clinica terapeutica 2001;152(3):203-6.
2001: Lopez M
[Development of cancer chemotherapy. Cytoprotective agents]
La Clinica terapeutica 2001;152(2):135-43.
2001: Lopez M
[Successful cancer chemotherapy. The cure of Hodgkin's disease. III]
La Clinica terapeutica 2001;152(1):57-63.
2001: Vici P; Belli F; Di Lauro L; Amodio A; Conti F; Foggi P; Gionfra T; Morelli M F; Botti C; Ferraironi A; Lopez M
Docetaxel in patients with anthracycline-resistant advanced breast cancer.
Oncology 2001;60(1):60-5.
2000: Lopez M
[Success in chemotherapy of cancer. The curing of Hodgkin's disease. II]
La Clinica terapeutica 2000;151(5):375-82.
2000: Maiello E; Gebbia V; Giuliani F; Paoletti G; Gebbia N; Cigolari S; Fortunato S; Pedicini T; Borsellino N; Lopez M; Colucci G
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1045-51.
2000: Lopez M
[The success of chemotherapy in cancer. Cure of Hodgkin's disease. I.]
La Clinica terapeutica 2000;151(4):293-300.
2000: Caponetti R; Amodio A; Naglieri E; Caponetti T; Crecco M; Lopez M
[Renal carcinoma: effective modulation of low-dose interferon-alpha and interleukin-2 with medroxyprogesterone acetate and 13-cis retinoic acid]
La Clinica terapeutica 2000;151(4):283-6.
2000: Lopez M
[Discovery of radioactivity and radium]
La Clinica terapeutica 2000;151(3):203-10.
2000: Lopez M
[The discovery of X-rays]
La Clinica terapeutica 2000;151(2):125-8.
2000: Lopez M
[Evolution of chemotherapy of cancer. Conceptuals models]
La Clinica terapeutica 2000;151(1):49-55.
2000: Vici P; Amodio A; Di Lauro L; Conti F; Gionfra T; Belli F; Lopez M
First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.
Oncology 2000;58(1):3-7.
1999: Lopez M
[Success of the chemotherapy of cancer. The cure of leukemia]
La Clinica terapeutica 1999;150(6):453-62.
1999: Lopez M
[The successes of cancer chemotherapy. The first cures of advanced-phase neoplasms]
La Clinica terapeutica 1999;150(5):383-7.
1999: Lopez M
[Development of cancer chemotherapy. Discovery of new active drugs. IV]
La Clinica terapeutica 1999;150(3):241-9.
1999: Lopez M
[Evolution of cancer chemotherapy. Discovery of new active drugs. III]
La Clinica terapeutica 1999;150(2):159-65.
1999: Carpano S; Amodio A; Bucher S; Foggi P; Vici P; Rinaldi M; Mariotti S; Del Monte G; Lopez M
[Chemotherapy of advanced stage melanoma using cisplatin, epirubicin and alpha-interferon]
La Clinica terapeutica 1999;150(2):109-14.
1999: Lopez M
[Dexrazoxane. Current status and prospectives of cardiotoxicity of chemotherapy]
La Clinica terapeutica 1999;150(1):37-49.
1999: Amodio A; Carpano S; Manfredi C; Del Monte G; Di Lauro L; Gionfra T; Conti F; Paoletti G; Lopez M
[Gemcitabine in advanced stage soft tissue sarcoma: a phase II study]
La Clinica terapeutica 1999;150(1):17-20.
1998: Lopez M
[Development of cancer chemotherapy. The discovery of new active drugs. II]
La Clinica terapeutica 1998;149(6):453-9.
1998: Amodio A; Crecco M; Del Medico P; Paoletti G; Lopez M
[Gemcitabine in peritoneal mesothelioma: a case report]
La Clinica terapeutica 1998;149(6):447-51.
1998: Lopez M
[Evolution of chemotherapy of cancer. Discovery of new drugs with antitumor activity I]
La Clinica terapeutica 1998;149(5):383-90.
1998: Lopez M; Carpano S; Amodio A; Gionfra T; Della Giulia M; Foggi P; Manfredi C; Del Monte G
Single-agent ifosfamide in the treatment of anthracycline-refractory adult sarcomas.
La Clinica terapeutica 1998;149(5):331-3.
1998: Vici P; Conti F; Amodio A; Belli F; Della Giulia M; Mariotti S; Gionfra T; Lopez M
[Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer]
La Clinica terapeutica 1998;149(4):255-9.
1998: Lopez M
[Evolution of chemotherapy of cancer. The initial phase]
La Clinica terapeutica 1998;149(2):155-9.
1998: Amodio A; Carpano S; Paoletti G; Gionfra T; Rinaldi M; Manfredi C; Foggi P; Lopez M
[Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma]
La Clinica terapeutica 1998;149(2):121-5.
1998: Paoletti G; Di Lauro L; Gionfra T; Venturo I; Belli F; Squilloni E; Mariotti S; Fioretti G; Gemini M; Tersigni R; Lopez M
[Sequential therapy with methotrexate and 5-fluorouracil in patients with advanced colorectal cancer pretreated with 5-fluorouracil plus folinic acid]
La Clinica terapeutica 1998;149(2):105-8.
1998: Lopez M
[Discovery of the AIDS virus]
La Clinica terapeutica 1998;149(921):79-86.
1998: Vici P; Ferraironi A; Di Lauro L; Carpano S; Conti F; Belli F; Paoletti G; Maini C L; Lopez M
Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment.
La Clinica terapeutica 1998;149(921):15-20.
1998: Lopez M; Vici P; Di Lauro K; Conti F; Paoletti G; Ferraironi A; Sciuto R; Giannarelli D; Maini C L
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):86-92.
1997: Maini C L; Sciuto R; Ferraironi A; Vici P; Tofani A; Festa A; Conti F; Lopez M
Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 1997;4(6):502-8.
1997: Maini C L; Tofani A; Sciuto R; Semprebene A; Cavaliere R; Mottolese M; Benevolo M; Ferranti F; Grandinetti M L; Vici P; Lopez M; Botti C
Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1546-51.
1997: Vici P; Di Lauro L; Conti F; Capomolla E; Gionfra T; Amodio A; Lopez M
Paclitaxel activity in anthracycline refractory breast cancer patients.
Tumori 1997;83(3):661-4.
1996: Vici P; Di Lauro L; Carpano S; Amodio A; Pignatti F; Casali A; Conti F; Lopez M
Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.
Oncology 1996;53(1):16-8.
1995: Lopez M; Di Lauro L; Paoletti G; Santini S; Gandolfo G M; Vitelli G; Frasca A M; Ameglio F; Rasi G; Garaci E
Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: clinical and immunological effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(10):1011-7.
1995: Garaci E; Lopez M; Bonsignore G; Della Giulia M; D'Aprile M; Favalli C; Rasi G; Santini S; Capomolla E; Vici P
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2403-5.
1995: Lopez M; Vici P; Di Lauro L; Paoletti G; Gionfra T; Conti F; Carpano S; Pignatti F; Giannarelli D
Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1611-4.
1995: Di Lauro L; Del Medico P; Carpano S; Cancrini A; Gionfra T; Vici P; Rosselli M; Lopez M
Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.
Tumori 1995;81(1):42-4.
1994: Lopez M; Carpano S; Cavaliere R; Di Lauro L; Ameglio F; Vitelli G; Frasca A M; Vici P; Pignatti F; Rosselli M
Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):741-6.
1994: Greco C; Ameglio F; Alvino S; Cianciulli A M; Giovannelli M; Mattei F; Vitelli G; Venturo I; Lopez M; Gandolfo G M
Selection of patients with monoclonal gammopathy of undetermined significance is mandatory for a reliable use of interleukin-6 and other nonspecific multiple myeloma serum markers.
Acta haematologica 1994;92(1):1-7.
1993: Lopez M; Carpano S; Cancrini A; Marcellini M; Del Medico P; Rinaldi M; Vici P; Paoletti G; Di Lauro L
Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):689-91.
1993: Lopez M; Natali M; Di Lauro L; Vici P; Pignatti F; Carpano S
Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.
Cancer 1993;72(2):502-5.
1991: Lopez M; Carpano S; Di Lauro L; Vici P; Conti E M
Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
Oncology 1991;48(3):230-3.
1991: Lopez M; Vici P; Carpano S; Natali M; Ganzina F; Conti E M; Di Lauro L
Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.
Journal of cancer research and clinical oncology 1991;117(1):61-4.
1991: Lopez M; Di Lauro L; Gionfra T; Gandolfo G; Ameglio F; Paoletti G
Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: preliminary results.
Journal of surgical oncology. Supplement 1991;2():108-11.
1990: Natali M; D'Aprile M; Tonini G; Leggio M; Vici P; Carpano S; Angelini F; Carassai A; Lopez M
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]
La Clinica terapeutica 1990;134(1):25-30.
1990: Lopez M; Natali M; Di Lauro L; Tonini G; Carpano S; Vici P; Conti E M
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer.
American journal of clinical oncology 1990;13(3):204-7.
1989: Angelini F; Coppetelli U; Carassai A; Lopez M
[Current results and prospects of intra-arterial chemotherapy in hepatic metastases of carcinoma of the colorectum]
La Clinica terapeutica 1989;130(6):303-17.
1989: Natali M; Tonini G; Tufo E; Leggio M; Carassai A; Lopez M
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]
La Clinica terapeutica 1989;130(5):239-44.
1989: Angelini F; Carassai A; Lopez M
[Chemotherapy of advanced ovarian carcinoma. II. Second-line treatment and new therapeutic modalities]
La Clinica terapeutica 1989;129(2):91-104.
1989: Lopez M; Papaldo P; Di Lauro L; Vici P; Carpano S; Conti E M
5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer.
Oncology 1989;46(1):1-5.
1988: Angelini F; Carassai A; Lopez M
[Chemotherapy of advanced ovarian carcinoma. I. First-choice treatment]
La Clinica terapeutica 1988;127(6):453-62.
1988: Natali M; Tonini G; Tufo E; Carassai A; Lopez M
[Neoplastic hypercalcemia]
La Clinica terapeutica 1988;127(3):189-201.
1987: Lopez M; Carassai A; Di Lauro L; Mignano M; Papaldo P; Vici P; Carpano S; Balice A; Di Gaetano G
[Colorectal carcinoma. II. Adjuvant therapy]
La Clinica terapeutica 1987;121(1):15-27.
1987: Lopez M; Carassai A; Di Lauro L; Papaldo P; Carpano S; Vici P; Mignano M; Di Gaetano G
[Colorectal cancer. I. Chemotherapy in the advanced stage]
La Clinica terapeutica 1987;120(6):473-87.
1986: Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Cancer treatment reports 1986;70(7):911-2.
1986: Lopez M; Vici P; Balice A; Carpano S; Papaldo P; Di Lauro L
[Current status of osteosarcoma therapy]
La Clinica terapeutica 1986;117(5):409-25.
1986: Lopez M; Vici P; Carpano S; Balice A; Di Lauro L; Papaldo P
[Ewing's sarcoma: current status of its therapy]
La Clinica terapeutica 1986;116(5):403-13.
1986: Lopez M; Di Lauro L; Papaldo P; Lazzaro B; Ganzina F; Di Pietro N
Phase II trial with oral idarubicin in advanced breast cancer.
Investigational new drugs 1986;4(1):39-42.
1985: Di Lauro L; Balice A; Carpano S; Papaldo P; Lopez M
[Mitomycin C and cisplatin as single agents in the second-line treatment of advanced gastric cancer]
La Clinica terapeutica 1985;115(5):361-4.
1985: Di Lauro L; Balice A; Papaldo P; Lopez M
[Mitomycin C in the treatment of sarcomas of the soft tissues in the adult in an advanced phase]
La Clinica terapeutica 1985;115(2):83-5.
1985: Lopez M; Perno C F; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N
Epirubicin in non-Hodgkin's lymphomas.
American journal of clinical oncology 1985;8(2):151-3.
1985: Lopez M; Di Lauro L; Papaldo P; Lazzaro B
Chemotherapy in metastatic male breast cancer.
Oncology 1985;42(4):205-9.
1985: Lopez M; Di Lauro L; Lazzaro B; Papaldo P
Hormonal treatment of disseminated male breast cancer.
Oncology 1985;42(6):345-9.
1984: Lopez M; Di Lauro L; Papaldo P; Perno C F
Alternating combination chemotherapy of advanced soft tissue sarcomas in adults.
American journal of clinical oncology 1984;7(5):539-42.
1984: Lopez M; Di Lauro L; Papaldo P; Lazzaro B
[Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma]
La Clinica terapeutica 1984;109(1):31-5.
1984: Lopez M; Perno C F; Papaldo P; Di Lauro L; Ganzina F; Barduagni A
Phase II study of epirubicin in advanced malignant melanoma.
Investigational new drugs 1984;2(3):315-7.
1984: Lopez M; Perno C F; Di Lauro L; Papaldo P; Ganzina F; Barduagni A
Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma.
Investigational new drugs 1984;2(3):319-22.
1983: Lopez M; Di Lauro L; Perno C F; Papaldo P; Barduagni M; Barduagni A
5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer.
Tumori 1983;69(6):545-51.
1983: Lopez M; Papaldo P; Perno C F; Di Lauro L; Barduagni A
[Toxicity of cisplatin administered with hydration of 1-hour duration and forced diuresis]
La Clinica terapeutica 1983;107(3):207-13.
1983: Lopez M; Papaldo P; Di Lauro L; Barduagni M; Perno C F; Barduagni A
Mitomycin C in patients with metastatic breast cancer refractory to hormone therapy and chemotherapy.
Oncology 1983;40(4):244-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Massimo Lopez

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Massimo Lopez (preview)

All Publications